Literature DB >> 15728917

Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel.

Jacob Schlesinger1, Shiri Navon-Venezia, Inna Chmelnitsky, Orly Hammer-Münz, Azita Leavitt, Howard S Gold, Mitchell J Schwaber, Yehuda Carmeli.   

Abstract

The extended-spectrum beta-lactamase (ESBL)-producing phenotype is frequent among Enterobacter isolates at the Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. We examined the clonal relatedness and characterized the ESBLs of a collection of these strains. Clonal relatedness was determined by pulsed-field gel electrophoresis. Isoelectric focusing (IEF) and transconjugation experiments were performed. ESBL gene families were screened by colony hybridization and PCR for bla(TEM), bla(SHV), bla(CTX-M), bla(IBC), bla(PER), bla(OXA), bla(VEB), and bla(SFO); and the PCR products were sequenced. The 17 Enterobacter isolates studied comprised 15 distinct genotypes. All isolates showed at least one IEF band (range, one to five bands) whose appearance was suppressed by addition of clavulanate; pIs ranged from 5.4 to > or = 8.2. Colony hybridization identified at least one family of beta-lactamase genes in 11 isolates: 10 harbored bla(TEM) and 9 harbored bla(SHV). PCR screening and sequence analysis of the PCR products for bla(TEM), bla(SHV), and bla(CTX-M) identified TEM-1 in 11 isolates, SHV-12 in 7 isolates, SHV-1 in 1 isolate, a CTX-M-2-like gene in 2 isolates, and CTX-M-26 in 1 isolate. In transconjugation experiments with four isolates harboring bla(TEM-1) and bla(SHV-12), both genes were simultaneously transferred to the recipient strain Escherichia coli HB101. Plasmid mapping, PCR, and Southern analysis with TEM- and SHV-specific probes demonstrated that a single transferred plasmid carried both the TEM-1 and the SHV-12 genes. The widespread presence of ESBLs among Enterobacter isolates in Tel Aviv is likely due not to clonal spread but, rather, to plasmid-mediated transfer, at times simultaneously, of genes encoding several types of enzymes. The dominant ESBL identified was SHV-12.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15728917      PMCID: PMC549242          DOI: 10.1128/AAC.49.3.1150-1156.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  39 in total

1.  IBC-1, a novel integron-associated class A beta-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain.

Authors:  P Giakkoupi; L S Tzouvelekis; A Tsakris; V Loukova; D Sofianou; E Tzelepi
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

2.  Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region.

Authors:  P L Winokur; R Canton; J M Casellas; N Legakis
Journal:  Clin Infect Dis       Date:  2001-05-15       Impact factor: 9.079

3.  Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum beta-lactamase to other members of the family enterobacteriaceae.

Authors:  C Neuwirth; E Siebor; J Lopez; A Pechinot; A Kazmierczak
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

4.  National epidemiologic surveys of Enterobacter aerogenes in Belgian hospitals from 1996 to 1998.

Authors:  Y De Gheldre; M J Struelens; Y Glupczynski; P De Mol; N Maes; C Nonhoff; H Chetoui; C Sion; O Ronveaux; M Vaneechoutte
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

5.  Concurrent outbreaks of extended-spectrum beta-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital.

Authors:  A Pałucha; B Mikiewicz; W Hryniewicz; M Gniadkowski
Journal:  J Antimicrob Chemother       Date:  1999-10       Impact factor: 5.790

Review 6.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

7.  Coexistence of SHV-4- and TEM-24-producing Enterobacter aerogenes strains before a large outbreak of TEM-24-producing strains in a French hospital.

Authors:  H Mammeri; G Laurans; M Eveillard; S Castelain; F Eb
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

8.  Molecular epidemiology of the integron-located VEB-1 extended-spectrum beta-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand.

Authors:  D Girlich; L Poirel; A Leelaporn; A Karim; C Tribuddharat; M Fennewald; P Nordmann
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

9.  Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate.

Authors:  G Barnaud; R Labia; L Raskine; M J Sanson-Le Pors; A Philippon; G Arlet
Journal:  FEMS Microbiol Lett       Date:  2001-02-20       Impact factor: 2.742

10.  Survey of prevalence of extended spectrum beta-lactamases among enterobacteriaceae.

Authors:  C Chanal; D Sirot; J P Romaszko; L Bret; J Sirot
Journal:  J Antimicrob Chemother       Date:  1996-07       Impact factor: 5.790

View more
  30 in total

1.  Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility.

Authors:  Oren Zimhony; Inna Chmelnitsky; Rita Bardenstein; Sorel Goland; Orly Hammer Muntz; Shiri Navon Venezia; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase-producing Enterobacteriaceae.

Authors:  Mitchell J Schwaber; Shiri Navon-Venezia; David Schwartz; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

3.  Utility of the VITEK 2 Advanced Expert System for identification of extended-spectrum beta-lactamase production in Enterobacter spp.

Authors:  Mitchell J Schwaber; Shiri Navon-Venezia; Inna Chmelnitsky; Azita Leavitt; David Schwartz; Yehuda Carmeli
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

4.  Recombination and selection can remove blaTEM alleles from bacterial populations.

Authors:  Joanna E Mroczkowska; Miriam Barlow
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

5.  Identification and characterization of CTX-M-producing Shigella isolates in the United States.

Authors:  Jason P Folster; Gary Pecic; Amy Krueger; Regan Rickert; Karen Burger; Alessandra Carattoli; Jean M Whichard
Journal:  Antimicrob Agents Chemother       Date:  2010-03-08       Impact factor: 5.191

6.  Characterization of a novel metallo-β-lactamase variant, GIM-2, from a clinical isolate of Enterobacter cloacae in Germany.

Authors:  Andreas F Wendel; Colin R MacKenzie
Journal:  Antimicrob Agents Chemother       Date:  2014-12-29       Impact factor: 5.191

7.  Outbreak of NDM-1-producing Klebsiella pneumoniae in a neonatal unit in Colombia.

Authors:  Javier Antonio Escobar Pérez; Narda María Olarte Escobar; Betsy Castro-Cardozo; Ismael Alberto Valderrama Márquez; Martha Isabel Garzón Aguilar; Leslie Martinez de la Barrera; Esther Rocio Barrero Barreto; Ricaurte Alejandro Marquez-Ortiz; Maria Victoria Moncada Guayazán; Natasha Vanegas Gómez
Journal:  Antimicrob Agents Chemother       Date:  2013-01-28       Impact factor: 5.191

8.  A swordless knight: epidemiology and molecular characteristics of the blaKPC-negative sequence type 258 Klebsiella pneumoniae clone.

Authors:  Amos Adler; Svetlana Paikin; Yelena Sterlin; Josef Glick; Rotem Edgar; Rima Aronov; Mitchell J Schwaber; Yehuda Carmeli
Journal:  J Clin Microbiol       Date:  2012-07-18       Impact factor: 5.948

9.  Ertapenem resistance among extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae isolates.

Authors:  Azita Leavitt; Inna Chmelnitsky; Raul Colodner; Itzhak Ofek; Yehuda Carmeli; Shiri Navon-Venezia
Journal:  J Clin Microbiol       Date:  2009-02-11       Impact factor: 5.948

10.  Characterization of CTX-M ESBLs in Enterobacter cloacae, Escherichia coli and Klebsiella pneumoniae clinical isolates from Cairo, Egypt.

Authors:  Noha G Khalaf; Mona M Eletreby; Nancy D Hanson
Journal:  BMC Infect Dis       Date:  2009-06-04       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.